Tetrahydrocannabinol (THC) Metabolite, Meconium, Qualitative
Also known as: CONFTHC M
Use
This test is used to detect and document fetal exposure to carboxy-THC during approximately the last trimester of a full-term pregnancy. It identifies a common metabolite of THC, which can be present in cannabis products. The test can help in understanding potential exposure but does not determine the pattern or frequency of maternal drug use. It is important to note that detection does not insinuate impairment and may not affect infant outcomes.
Special Instructions
Not provided.
Limitations
This test does not distinguish between the delta-8 and delta-9 forms of THC or their metabolites. A negative result does not exclude the possibility of drug use during pregnancy. The test does not provide information on the frequency or pattern of maternal drug use. Detection of THC in meconium depends on various factors including drug stability, deposition characteristics, and the analytical method. Drugs administered to the mother during labor or directly to the infant can also be detected.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Carboxy-THC
Analyte
LOINC Codes
- 27024-9 - Cannabinoids Mec-mCnt
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Container
Routine urine collection cup or Security Kit for Meconium/Umbilical Drug Detection (ARUP supply #51548)
Collection Instructions
Transport all available meconium to the appropriate collection container.
Patient Preparation
Collect all meconium excreted until milk/formula based stool appears.
Storage Instructions
Store at room temperature.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 3 months |
| Frozen | 1 year |
Other tests from different labs that may be relevant